Report Thumbnail
Product Code IW091401844HIY
Published Date 2021/12/14
English244 PagesGlobal

GLOBAL COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code IW091401844HIY◆The Dec 2025 edition is also likely available. We will check with the publisher immediately.
Published Date 2021/12/14
English 244 PagesGlobal

GLOBAL COSMETIC SURGERY AND PROCEDURE MARKET FORECAST 2022-2030Pharmaceutical_LifeSciense Market



Abstract


Summary

KEY FINDINGS The global cosmetic surgery and procedure market is evaluated to register a CAGR of 5.43% over the forecasting years of 2022 to 2030. The market growth is reinforced by the rise in the aging population, the growth of the aesthetic industry, the preference for minimally invasive and non-invasive procedures over invasive procedures, and medical tourism in developing economies. MARKET INSIGHTS Cosmetic surgery entails a type of plastic surgery that aims to enhance a person’s appearance. Since it emerged from reconstructive surgeries, cosmetic as well as reconstructive procedures have similar techniques. For instance, in several reconstructive procedures, including suction-assisted lipectomy, liposuction is utilized to eliminate fatty deposits and fatty tumors. However, it has a wider application across cosmetic techniques for removing unwanted fat and streamlining body shape. The medical tourism industry has continued to experience rapid growth globally. With rising healthcare costs, in addition to long waiting times from strained public health systems across several countries, developing markets are gaining prominence owing to the affordable, safe, high-quality, and swift healthcare system. Factually, medical tourism was associated with dentistry and cosmetic surgery. However, over the last decade, medical tourism has been allied with a wide spectrum of procedures and surgeries. REGIONAL INSIGHTS The global cosmetic surgery and procedure market growth assessment constitutes the analysis of North America, Asia-Pacific, Europe, and Rest of World. The Asia-Pacific is anticipated to grow with the highest CAGR during the forecasted years on account of the increasing aging population, the rising rates of obesity, a surge in skin-related problems, and the growing incidence of breast cancer. COMPETITIVE INSIGHTS The global cosmetic surgery and procedure market is fragmented. Moreover, manufacturers strive to elevate their market share through the introduction of new technology-based products and competitive pricing. As a result, the industrial rivalry among existing players is high. Some of the key companies operating in the market are Merz Pharma, Allergan, Johnson & Johnson, etc. Our report offerings include: • Explore key findings of the overall market • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges) • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions • Market Segmentation cater to a thorough assessment of key segments with their market estimations • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc. • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc. • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

  • 1 RESEARCH SCOPE & METHODOLOGY

    • 1.1 STUDY OBJECTIVES
    • 1.2 SCOPE OF STUDY
    • 1.3 METHODOLOGY
    • 1.4 ASSUMPTIONS & LIMITATIONS
  • 2 EXECUTIVE SUMMARY

    • 2.1 MARKET SIZE & ESTIMATES
    • 2.2 MARKET OVERVIEW
  • 3 MARKET DYNAMICS

    • 3.1 KEY DRIVERS
      • 3.1.1 AGING POPULATION LEADS TO AN INCREASED DEMAND FOR ANTI-AGING COSMETIC AND AESTHETIC TREATMENTS
      • 3.1.2 GROWTH OF THE AESTHETIC INDUSTRY
      • 3.1.3 MEDICAL TOURISM IN DEVELOPING MARKETS
      • 3.1.4 PREFERENCE FOR MINIMALLY INVASIVE AND NON-INVASIVE PROCEDURES OVER INVASIVE PROCEDURES
    • 3.2 KEY RESTRAINTS
      • 3.2.1 HIGH RATE OF AESTHETIC USAGES AND IMPLANTABLE MEDICAL DEVICES
      • 3.2.2 DIFFICULTIES RELATED TO COSMETIC TREATMENT
      • 3.2.3 SAFETY CONCERNS RELATED TO BREAST IMPLANT
  • 4 KEY ANALYTICS

    • 4.1 IMPACT OF COVID-19 ON COSMETIC SURGERY AND PROCEDURE MARKET
    • 4.2 KEY MARKET TRENDS
    • 4.3 PORTER’S FIVE FORCES ANALYSIS
      • 4.3.1 BUYERS POWER
      • 4.3.2 SUPPLIERS POWER
      • 4.3.3 NEW ENTRY
      • 4.3.4 SUBSTITUTION
      • 4.3.5 INDUSTRY RIVALRY
    • 4.4 VALUE CHAIN ANALYSIS
    • 4.5 REGULATORY FRAMEWORK
    • 4.6 OPPORTUNITY MATRIX
    • 4.7 VENDOR LANDSCAPE
  • 5 MARKET BY TYPE

    • 5.1 SURGICAL
      • 5.1.1 BREAST AUGMENTATION
      • 5.1.2 LIPOSUCTION
        • 5.1.2.1 LASER ASSISTED LIPOSUCTION
        • 5.1.2.2 RADIO FREQUENCY ASSISTED LIPOSUCTION
        • 5.1.2.3 ULTRASOUND ASSISTED LIPOSUCTION
        • 5.1.2.4 OTHER LIPOSUCTION
      • 5.1.3 EYELID SURGERY
      • 5.1.4 TUMMY TUCK
      • 5.1.5 BREAST LIFT
      • 5.1.6 OTHER SURGICAL TYPES
    • 5.2 NON-SURGICAL
      • 5.2.1 BOTULINUM TOXIN
      • 5.2.2 DERMAL FILLERS
      • 5.2.3 LASER HAIR REMOVAL
      • 5.2.4 CHEMICAL PEEL
      • 5.2.5 MICRODERMABRASION
      • 5.2.6 PHOTO-REJUVENATION
      • 5.2.7 OTHER NON-SURGICAL TYPES
  • 6 GEOGRAPHICAL ANALYSIS

    • 6.1 NORTH AMERICA
      • 6.1.1 MARKET SIZE & ESTIMATES
      • 6.1.2 KEY GROWTH ENABLERS
      • 6.1.3 KEY CHALLENGES
      • 6.1.4 KEY PLAYERS
      • 6.1.5 COUNTRY ANALYSIS
        • 6.1.5.1 UNITED STATES
        • 6.1.5.2 CANADA
    • 6.2 EUROPE
      • 6.2.1 MARKET SIZE & ESTIMATES
      • 6.2.2 KEY GROWTH ENABLERS
      • 6.2.3 KEY CHALLENGES
      • 6.2.4 KEY PLAYERS
      • 6.2.5 COUNTRY ANALYSIS
        • 6.2.5.1 GERMANY
        • 6.2.5.2 UNITED KINGDOM
        • 6.2.5.3 FRANCE
        • 6.2.5.4 ITALY
        • 6.2.5.5 RUSSIA
        • 6.2.5.6 BELGIUM
        • 6.2.5.7 POLAND
        • 6.2.5.8 REST OF EUROPE
    • 6.3 ASIA-PACIFIC
      • 6.3.1 KEY GROWTH ENABLERS
      • 6.3.2 KEY CHALLENGES
      • 6.3.3 KEY PLAYERS
      • 6.3.4 COUNTRY ANALYSIS
        • 6.3.4.1 CHINA
        • 6.3.4.2 JAPAN
        • 6.3.4.3 INDIA
        • 6.3.4.4 AUSTRALIA & NEW ZEALAND
        • 6.3.4.5 SOUTH KOREA
        • 6.3.4.6 THAILAND
        • 6.3.4.7 INDONESIA
        • 6.3.4.8 VIETNAM
        • 6.3.4.9 MYANMAR
        • 6.3.4.10 REST OF ASIA-PACIFIC
    • 6.4 REST OF WORLD
      • 6.4.1 MARKET SIZE & ESTIMATES
      • 6.4.2 KEY GROWTH ENABLERS
      • 6.4.3 KEY CHALLENGES
      • 6.4.4 KEY PLAYERS
      • 6.4.5 REGIONAL ANALYSIS
        • 6.4.5.1 LATIN AMERICA
        • 6.4.5.2 MIDDLE EAST & AFRICA
  • 7 COMPETITIVE LANDSCAPE

    • 7.1 KEY STRATEGIC DEVELOPMENTS
      • 7.1.1 MERGERS & ACQUISITIONS
      • 7.1.2 PRODUCT LAUNCHES & DEVELOPMENTS
      • 7.1.3 PARTNERSHIPS & AGREEMENTS
      • 7.1.4 BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
    • 7.2 COMPANY PROFILES
      • 7.2.1 ALLERGAN PLC (ACQUIRED BY ABBVIE)
      • 7.2.2 ALMA LASERS LTD (ACQUIRED BY FOSUN PHARMA)
      • 7.2.3 BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
      • 7.2.4 CANDELA CORP (FORMERLY SYNERON MEDICAL LTD)
      • 7.2.5 CUTERA INC
      • 7.2.6 CYNOSURE (ACQUIRED BY CLAYTON, DUBILIER & RICE)
      • 7.2.7 GALDERMA (ACQUIRED BY EQT)
      • 7.2.8 IPSEN SA
      • 7.2.9 JOHNSON & JOHNSON
      • 7.2.10 LUMENIS LTD
      • 7.2.11 MERZ PHARMA
      • 7.2.12 SIENTRA INC
      • 7.2.13 SINCLAIR PHARMA PLC
USD 2,900 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.